<VariationArchive VariationID="3246302" VariationName="NC_000005.9:g.(?_131721179)_(131726510_?)del" VariationType="Deletion" Accession="VCV003246302" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3402453" VariationID="3246302">
      <GeneList>
        <Gene Symbol="SLC22A5" FullName="solute carrier family 22 member 5" GeneID="6584" HGNC_ID="HGNC:10969" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q31.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="132369710" stop="132395612" display_start="132369710" display_stop="132395612" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="131705400" stop="131731305" display_start="131705400" display_stop="131731305" Strand="+" />
          </Location>
          <OMIM>603377</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000005.9:g.(?_131721179)_(131726510_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q31.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" innerStart="131721179" innerStop="131726510" display_start="131721179" display_stop="131726510" variantLength="5332" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.(?_131721179)_(131726510_?)del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.(?_131721179)_(131726510_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000005.9:g.(?_131721179)_(131726510_?)del AND Renal carnitine transport defect" Accession="RCV004578946" Version="1">
        <ClassifiedConditionList TraitSetID="1778">
          <ClassifiedCondition DB="MedGen" ID="C0342788">Renal carnitine transport defect</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-10-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-10-12" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">28841266</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9916797</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1778" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1316" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Primary carnitine deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carnitine uptake defect</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carnitine deficiency, systemic, due to defect in renal reabsorption of carnitine</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carnitine plasma-membrane transporter deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARNITINE TRANSPORTER, PLASMA-MEMBRANE, DEFICIENCY OF</ElementValue>
                <XRef Type="MIM" ID="212140" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carnitine Deficiency, Systemic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Systemic primary carnitine deficiency disease</ElementValue>
                <XRef ID="MONDO:0008919" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Renal carnitine transport defect</ElementValue>
                <XRef ID="Renal+carnitine+transport+defect/9212" DB="Genetic Alliance" />
                <XRef ID="21764004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carnitine transporter deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CUD</ElementValue>
                <XRef Type="MIM" ID="212140" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">CDSP</ElementValue>
                <XRef Type="MIM" ID="212140" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SCD</ElementValue>
                <XRef Type="MIM" ID="212140" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Systemic primary carnitine deficiency (CDSP) is a disorder of the carnitine cycle that results in defective fatty acid oxidation. It encompasses a broad clinical spectrum including the following: Metabolic decompensation in infancy typically presenting between age three months and two years with episodes of hypoketotic hypoglycemia, poor feeding, irritability, lethargy, hepatomegaly, elevated liver transaminases, and hyperammonemia triggered by fasting or common illnesses such as upper respiratory tract infection or gastroenteritis. Childhood myopathy involving heart and skeletal muscle with onset between age two and four years. Pregnancy-related decreased stamina or exacerbation of cardiac arrhythmia. Fatigability in adulthood. Absence of symptoms. The latter two categories often include mothers diagnosed with CDSP after newborn screening has identified low carnitine levels in their infants.</Attribute>
                <XRef ID="NBK84551" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5104" />
                <XRef ID="5104" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22420015</ID>
                <ID Source="BookShelf">NBK84551</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Carnitine-Uptake-Defect-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased C0, Carnitine Uptake Defect (CUD; Primary Carnitine Deficiency), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C0-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Carnitine Uptake Defect: Decreased C0 (Free Carnitine), 2022</CitationText>
              </Citation>
              <XRef ID="158" DB="Orphanet" />
              <XRef ID="C0342788" DB="MedGen" />
              <XRef ID="MONDO:0008919" DB="MONDO" />
              <XRef Type="MIM" ID="212140" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9836834" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000005.9:g.(?_131721179)_(131726510_?)del|MedGen:C0342788" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005062937" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9916797</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28841266</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in SLC22A5 are known to be pathogenic (PMID: 9916797). This variant disrupts the p.Ser280 amino acid residue in SLC22A5. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 28841266). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. This variant has not been reported in the literature in individuals with SLC22A5-related conditions. This variant is a deletion of the genomic region encompassing exons 5-6 and part of exons 4 and 7 (c.812_1181delinsGG) of the SLC22A5 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.(?_131721179)_(131726510_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0342788" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9836834" TraitType="Disease" MappingType="XRef" MappingValue="C0342788" MappingRef="MedGen">
        <MedGen CUI="C0342788" Name="Renal carnitine transport defect" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

